A study by University of Sydney researchers looked at the “efficacy and safety of paracetamol for pain relief” in treating 44 painful conditions including knee or hip osteoarthritis, headaches and acute low back pain. For most conditions, evidence regarding the effectiveness of paracetamol is “insufficient for drawing a firm conclusion”. While the evidence for paracetamol’s efficacy in four conditions was moderate to strong, there is strong evidence it is not effective for reducing acute low back pain. See Painaustralia’s board member Sister May-Lynne Cochrane, who has experienced lower back pain nearly 40 years, in the Channel 9 news story here.
...The third project, the Community Education and Awareness Program, is run by Painaustralia and aims to offer people easy access to pain management information. “This is intended to be a trusted source of quality information in one place that enables people to get informed about what’s available out there,” says Carol Bennett, CEO at Painaustralia. The program includes a range of resources and links to research studies, a discussion forum and an app where people can interact and ask questions...
...Leah Dwyer, Painaustralia Consumer Advisory Group Memeber, who became hooked after using the drugs to treat chronic neck pain, said: “When I took these pills, I felt quite like, ‘She’ll be right, I can handle this.’ It gives you a sense of euphoria and control. It’s opium – that’s the part I think people forget. They make you not care about the pain.”
Eventually, Ms Dwyer was taking 15 pills a day. Her life came to revolve around them. But when she quit, she found the pain was not as bad as she had feared and easily treatable with Panadol...
Last June, the Australian government introduced regulatory changes in opioids prescriptions to face this crisis. But restricting access to opioids without offering valid alternatives has left many Australians in pain.
“The challenge is to restrict the uptake and ongoing use of opioids for pain while ensuring patients continue to have access to safe, effective and adequate pain relief,” says Carol Bennett, CEO of national peak body painaustralia. “This study provides some insight into one mechanism for achieving this.”
Sophie ScottABC News interviewed Painaustralia CEO Carol Bennett about new restrictions on the use and availability of opioid medication, particularly for chronic pain management. Many people have been left without access to affordable alternative services, and are finding it very difficult to cope. https://iview.abc.net.au/video/NU2109H048S00
ABC News - 09/03/2021
Mary Lloyd & Sophie ScottABC News interviewed Painaustralia CEO Carol Bennett about new restrictions on the use and availability of opioid medication, particularly for chronic pain management. Here is the full interview! #painaustralia also available on
RACV launches new survey to address driving with chronic pain.
Many drivers can feel their muscles twinge after a long stint behind the wheel but for people with chronic pain, the challenge of driving for prolonged periods can impact their everyday lives. Experts say 14 per cent of Australians – 3.5 million people – suffer chronic pain, but many want to continue to drive.
The Therapeutic Goods Administration (TGA) announced on 15 December a final decision to down-schedule certain low dose cannabidiol (CBD) preparations from Schedule 4 (Prescription Medicine) to Schedule 3 (Pharmacist Only Medicine).
According to a statement released by the TGA this decision allows approved low-dose CBD-containing products (up to a maximum of 150mg/day) for use in adults, to be supplied OTC by a pharmacist, without prescription.
Painaustralia CEO speaks on tighter regulation of opioid use, #COVID19, and broader need for multidisciplinary pain management in Australia in the June 2020 issue of Retail Pharmacy. https://buff.ly/2U7DMPk
Researchers at the University of Sydney have used human stem cells to make pain-killing neurons that provide lasting relief in mice, without side effects, in a single treatment. Prof Paul Glare interviewed https://buff.ly/2U0Fwe9 ( also aired on Channel 10 News)